Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $11,204 - $13,693
-55 Reduced 2.32%
2,316 $545,000
Q2 2022

Aug 15, 2022

BUY
$213.86 - $277.87 $28,871 - $37,512
135 Added 6.04%
2,371 $556,000
Q1 2022

May 11, 2022

BUY
$259.82 - $298.18 $83,142 - $95,417
320 Added 16.7%
2,236 $590,000
Q4 2021

Feb 15, 2022

SELL
$271.6 - $314.21 $17,654 - $20,423
-65 Reduced 3.28%
1,916 $602,000
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $14,015 - $15,725
51 Added 2.64%
1,981 $558,000
Q2 2021

Aug 13, 2021

SELL
$251.87 - $278.14 $2,014 - $2,225
-8 Reduced 0.41%
1,930 $532,000
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $397,057 - $494,248
1,938 New
1,938 $494,000
Q4 2018

Feb 13, 2019

SELL
$120.82 - $174.09 $187,150 - $269,665
-1,549 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$160.33 - $189.41 $248,351 - $293,396
1,549 New
1,549 $278,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.